HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years].

Abstract
Ciprofloxacin 500 mg orally twice daily was compared to pivampicillin 700 mg orally twice daily for 10 days in 172 men (41-85 years) with acute epididymitis. Failure of treatment occurred in 48 patients, in 15/76 (19.7%) receiving ciprofloxacin versus in 33/82 (40.2%) receiving pivampicillin (p = 0.006). Ciprofloxacin 500 mg orally twice daily is more effective than pivampicillin 700 mg orally twice daily and has fewer adverse events.
AuthorsJ H Eickhoff, N Frimodt-Møller, S Walter, C Frimodt-Møller
JournalUgeskrift for laeger (Ugeskr Laeger) Vol. 162 Issue 7 Pg. 936-9 (Feb 14 2000) ISSN: 0041-5782 [Print] Denmark
Vernacular TitleCiprofloxacin og pivampicillin ved epididymitis acuta hos maend over 40 år.
PMID10740436 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Infective Agents
  • Penicillins
  • Pivampicillin
  • Ciprofloxacin
Topics
  • Acute Disease
  • Administration, Oral
  • Adult
  • Aged
  • Anti-Infective Agents (administration & dosage, therapeutic use)
  • Ciprofloxacin (administration & dosage, therapeutic use)
  • Double-Blind Method
  • Epididymitis (drug therapy, microbiology)
  • Humans
  • Male
  • Middle Aged
  • Penicillins (administration & dosage, therapeutic use)
  • Pivampicillin (administration & dosage, therapeutic use)
  • Prospective Studies
  • Recurrence
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: